NIH said Tuesday it chose 12 research teams to develop methods to personalize care based on patient DNA sequence data through the Electronic Medical Records and Genomics integration program.
âThe newly funded projects are focused on discovering genes and gene variants with clinical implications by using the latest sequencing technologies to examine rare and common variants suspected to relate to disease risk and treatment effects,â said Rongling Li, eMERGE program director at NIH’s National Human Genome Research Institute.
Researchers will also assess the economic and psychological impacts of the use of genomic information on patients and their families, NIH noted.